‘Smart’ new drug shows promise in ovarian cancerNovember 9th, 2010 - 2:41 pm ICT by IANS
London, Nov 9 (IANS) Sixty percent of women with ovarian cancer could be helped by a new ’smart’ drug treatment currently being developed, say scientists.
Until now it was only thought that those who had ovarian cancer as a result of carrying an inherited “faulty” copy of the BRCA gene, accounting for up to 15 percent of cases, would benefit from a class of drug called PARP inhibitors.
PARP, the enzyme Poly ADP ribose polymerase, are developed for multiple indications, the most important is the treatment of cancer.
But now scientists have developed a new test that shows 60 percent of all patients with ovarian cancer could benefit from them, reports the Telegraph.
Every year almost 7,000 women in the UK alone are diagnosed with ovarian cancer. Survival rates are poor, principally because the disease is often picked up late.
Currently there are no PARP inhibitor drugs licensed to treat ovarian cancer patients. A handful such as olaparib have shown promising results at reducing tumours in early trials.
Asima Mukhopadhyay of the Northern Gynaecological Oncology Centre in Gateshead, UK, presented results of the research at the National Cancer Research Institute conference in Liverpool Monday.
“Our results show that this new test is almost 100 percent effective in identifying which ovarian cancer patients could benefit from these promising new drugs,” Mukhopadhyay said.
- New ovarian and breast cancer treatments - Feb 23, 2010
- Revolutionary therapy shows promise for breast cancer patients: Lancet - Jul 06, 2010
- Wonder drug could kill all types of cancer - Jun 27, 2011
- New drug shows promise against ovarian and breast cancer - Aug 13, 2010
- Function of potential cancer-causing gene product uncovered - Aug 08, 2009
- New therapy eradicates cancer cells without targeting healthy ones - Nov 05, 2009
- 'Wonder drug' a true cancer-buster - Sep 16, 2009
- Study sheds light on cause of stomach cancer - Jan 07, 2010
- New genetic marker of ovarian cancer risk discovered - Jul 21, 2010
- New genetic links to ovarian cancer risk discovered - Sep 20, 2010
- New drug may help cure breast and ovarian cancer - Jul 07, 2010
- Cancer drug could combat ovarian tumours - Oct 12, 2010
- Smoking linked to ovarian cancer? - Sep 12, 2012
- New drug olaparib may hold promise for women with genetic breast cancer - Jun 01, 2009
- 'Space Age' cancer drug shows promise - Jun 25, 2009
Tags: adp, brca gene, cancer research institute, cancer survival rates, gateshead uk, gynaecological oncology, handful, mukhopadhyay, national cancer, new drugs, new test, oncology, ovarian cancer, ovarian cancer patients, ovarian cancer survival rates, polymerase, promising results, smart drug, treatment of cancer, tumours